Dimethyl fumarate (Tecfidera) price

Dimethyl fumarate (Tecfidera) is an oral drug used to treat multiple sclerosis (Multiple Sclerosis, MS) and is an immunomodulator. Its main component is dimethyl fumarate, which slows down the progression of MS symptoms by regulating the activity of the immune system.

The original drug of dimethyl fumarate has been launched in China and has been included in medical insurance. Patients can buy it domestically at a price of about 5,000 to 6,000 yuan. Please consult the local hospital pharmacy for specific prices. The main foreign drug is dimethyl fumarate original drug. The cheaper one is the Indian original drug, which costs more than 2,000 yuan and has the same composition and efficacy as the domestic original drug.

Tecfidera's mechanism involves inhibiting the activity of immune cells and reducing their attack on the central nervous system, thereby helping to reduce symptoms and disease progression in MS patients. Compared with traditional injection therapy, Tecfidera's oral administration provides patients with a more convenient treatment option.

However, usingTecfiderais not without risks. Some patients may experience gastrointestinal discomfort, such as diarrhea, nausea, and abdominal pain during the initial treatment phase, although these symptoms usually lessen over the course of treatment. In addition, a small number of patients may face more serious side effects, such as low white blood cell counts, abnormal liver function, and allergic reactions. Therefore, before using Tecfidera, doctors usually consider the patient's health status, ensure that the patient is suitable for the drug, and conduct regular monitoring to evaluate the efficacy and side effects.

Overall, Tecfidera represents an advancement in the treatment of multiple sclerosis and provides patients with a more convenient treatment option. However, patients still need to pay close attention to possible side effects during use and maintain communication with their doctors to ensure safe and effective management of the condition.